Crossmark

The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression

Crossref DOI link: https://doi.org/10.1186/1756-8722-7-34

Published Online: 2014-04-16

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Xiaolei

Xu, Meng

Wei, Yongqiang

Huang, Fen

Zhao, Tong

Li, Xiangzhao

Feng, Ru

Ye, B Hilda
More Information

Article History

Received: 21 February 2014

Accepted: 24 March 2014

First Online: 16 April 2014